Difference between revisions of "Template:Heidelberg/pages/overview/aptamers"
(15 intermediate revisions by 3 users not shown) | |||
Line 12: | Line 12: | ||
<div class="panel‐body"> | <div class="panel‐body"> | ||
<div class="row"> | <div class="row"> | ||
− | <div class="col-lg- | + | |
− | + | <div class="col-lg-2" style="margin-top:-25px;"> | |
<div class="imagewrapper"> | <div class="imagewrapper"> | ||
<div class="imagewrapperheader"> | <div class="imagewrapperheader"> | ||
Line 31: | Line 31: | ||
</div> | </div> | ||
<p class="basictext"> | <p class="basictext"> | ||
− | Aptamers are RNA or DNA sequences that can selectively bind to a ligand or target. Scientists have selected a variety of aptamers for small molecules ranging from theophylline (Fig. 4A) being one of the first described aptamers<x-ref> | + | Aptamers are RNA or DNA sequences that can selectively bind to a ligand or target. Scientists have selected a variety of aptamers for small molecules ranging from theophylline (Fig. 4A) being one of the first described aptamers<x-ref>Jenison1994</x-ref> over ATP<x-ref>Sassanfar1993</x-ref> to an aptamer for the protein thrombin<x-ref>Bock1992</x-ref>. |
</p> | </p> | ||
<p class="basictext"> | <p class="basictext"> | ||
− | Both catalytic nucleic acids and aptamers are as for today selected via systematic evolution of ligands by exponential enhancement<x-ref>Joyce1989</x-ref><x-ref> | + | Both catalytic nucleic acids and aptamers are as for today selected via systematic evolution of ligands by exponential enhancement<x-ref>Joyce1989</x-ref><x-ref>Ellington1990</x-ref><x-ref>Tuerk1990</x-ref><x-ref>Bartel1993</x-ref> also known as SELEX (Fig. 5). It is a very time consuming and expensive process. Many cycles of selection from a random pool of sequences have to be performed in order select the best candidates in each round. A variable starting pool of random sequences has to be prepared and after every cycle the candidates have to be mutated to further improve the binding to the target. All in all the process is rather inefficient. Probably this is the reason why there are still many small molecules and proteins for which no aptamer has been published yet. |
</p> | </p> | ||
− | |||
<p class="basictext"> | <p class="basictext"> | ||
− | It has been shown that selected aptamers can be used to make the catalytic activity dependent on the presence of a ligand.<x-ref>Soukup1999</x-ref> Fusions like that are called aptazymes. For this a catalytic domain has to interact via a communication module with an aptamer (Fig. 6). In presence of the ligand the aptamer undergoes conformational changes which results in an activation or inactivation of the catalytic activity. In our project we use different aptamers and combine them with catalytic nucleic acids to use them in various applications. In order to develop the necessary tools we need a fast and efficient way to generate new aptamers and aptazymes. To meet these needs we have developed two parts of software: One that generates aptamers from scratch (MAWS) and another one that joins them with an existing catalytic nucleic acid(JAWS) in an optimized way. This method not only is faster but also cheaper than existing methods. | + | It has been shown that selected aptamers can be used to make the catalytic activity dependent on the presence of a ligand.<x-ref>Soukup1999</x-ref> Fusions like that are called aptazymes. For this a catalytic domain has to interact via a communication module with an aptamer (Fig. 6). In presence of the ligand the aptamer undergoes conformational changes which results in an activation or inactivation of the catalytic activity. In our project we use different aptamers and combine them with catalytic nucleic acids to use them in various applications. In order to develop the necessary tools we need a fast and efficient way to generate new aptamers and aptazymes. To meet these needs we have developed two parts of software: One that generates aptamers from scratch (MAWS) and another one that joins them with an existing catalytic nucleic acid (JAWS) in an optimized way. This method not only is faster but also cheaper than existing methods. |
</p> | </p> | ||
− | <div class="col-lg- | + | </div> |
+ | <div class="row"> | ||
+ | <div class="col-lg-4"> | ||
<div class="imagewrapper"> | <div class="imagewrapper"> | ||
<div class="imagewrapperheader"> | <div class="imagewrapperheader"> | ||
</div> | </div> | ||
<div class="imagewrapperimage"> | <div class="imagewrapperimage"> | ||
− | <img class="img-responsive" src="https://static.igem.org/mediawiki/2015/ | + | <img class="img-responsive" src="https://static.igem.org/mediawiki/2015/6/6b/3_Switch.svg"> |
</div> | </div> | ||
<div class="imagewrappercaption"> | <div class="imagewrappercaption"> | ||
<strong> | <strong> | ||
− | + | Figure 6. Aptazyme | |
</strong> | </strong> | ||
<p class="basictext"> | <p class="basictext"> | ||
− | + | An aptamer connected via a communication module to an catalytic sequence; The communication module translates the interaction of the ligand with the aptamer to the catalytic part of the aptazyme. | |
</p> | </p> | ||
</div> | </div> | ||
</div> | </div> | ||
</div> | </div> | ||
− | <div class="col-lg- | + | <div class="col-lg-8"> |
<div class="imagewrapper"> | <div class="imagewrapper"> | ||
<div class="imagewrapperheader"> | <div class="imagewrapperheader"> | ||
</div> | </div> | ||
<div class="imagewrapperimage"> | <div class="imagewrapperimage"> | ||
− | <img class="img-responsive" src=" | + | <img class="img-responsive" src="https://static.igem.org/mediawiki/2015/b/bb/Fig5SELEX.jpg"> |
</div> | </div> | ||
<div class="imagewrappercaption"> | <div class="imagewrappercaption"> | ||
<strong> | <strong> | ||
− | + | Figure 5. SELEX | |
</strong> | </strong> | ||
<p class="basictext"> | <p class="basictext"> | ||
− | + | Systematic Evolution of Ligands by EXponential Enrichment (SELEX): Current method to select functional nucleic acids from a random library. Figure adapted from: <a href="http://www.creative-biogene.com/Services/Aptamers/Technology-Platforms.html">Source</a> | |
</p> | </p> | ||
</div> | </div> | ||
</div> | </div> | ||
</div> | </div> | ||
− | < | + | </div> |
− | + | <div class="row"> | |
− | + | <div class="col-lg-4" style="witdth:30%;"> | |
− | <div class="col-lg-4"> | + | |
<div class="imagewrapper"> | <div class="imagewrapper"> | ||
<div class="imagewrapperheader"> | <div class="imagewrapperheader"> | ||
Line 86: | Line 86: | ||
<div class="imagewrappercaption"> | <div class="imagewrappercaption"> | ||
<strong> | <strong> | ||
− | + | Figure 7. Spinach Aptamer | |
</strong> | </strong> | ||
<p class="basictext"> | <p class="basictext"> | ||
− | + | The Spinach Aptamer turns on fluorescence of its ligand upon bind it. | |
</p> | </p> | ||
</div> | </div> | ||
</div> | </div> | ||
</div> | </div> | ||
+ | <div class="col-lg-8"> | ||
+ | <p class="basictext"> | ||
+ | Besides the above describes functional nucleic acids SELEX revealed aptamers which not only bind to a ligand but also are able to turn on fluorescence of different non-fluorescent dyes. An interesting example for an aptamer with such a special function is the Malachite Green Aptamer.<x-ref>Grate1999</x-ref> In presence of malachite green the aptamer turns on the fluorescence of the dye.<x-ref>Babendure2003</x-ref> In 2011 Jaffrey selected the famous Spinach RNA aptamer (Fig. 7). It binds a small molecule that resembles the fluorophore of the green fluorescent protein (GFP).<x-ref>Paige2011</x-ref> Upon binding of the small molecule to the Spinach a green fluorescence comparable to that of the GFP is emitted. In our project we use variants of these fluorescent aptamers and engineer them to be dependent on small molecules of our interest. | ||
+ | </p> | ||
<p class="basictext"> | <p class="basictext"> | ||
Though we so far mainly discussed functional RNA there are also both DNA aptamers and catalytic DNA which were selected using SELEX as well. As for today the concept of functional nucleic acids in nature has only been found for RNA. Nevertheless DNA aptamers and also catalytic DNA were selected <i>in vitro</i>. | Though we so far mainly discussed functional RNA there are also both DNA aptamers and catalytic DNA which were selected using SELEX as well. As for today the concept of functional nucleic acids in nature has only been found for RNA. Nevertheless DNA aptamers and also catalytic DNA were selected <i>in vitro</i>. | ||
</p> | </p> | ||
− | </div | + | </div> |
− | </div> | + | </div> |
+ | |||
</div> <!-- panel-body --> | </div> <!-- panel-body --> | ||
</div> <!-- panel panel‐default --> | </div> <!-- panel panel‐default --> |
Latest revision as of 02:18, 19 September 2015
Aptamers
Aptamers are RNA or DNA sequences that can selectively bind to a ligand or target. Scientists have selected a variety of aptamers for small molecules ranging from theophylline (Fig. 4A) being one of the first described aptamers
Both catalytic nucleic acids and aptamers are as for today selected via systematic evolution of ligands by exponential enhancement
It has been shown that selected aptamers can be used to make the catalytic activity dependent on the presence of a ligand.
Besides the above describes functional nucleic acids SELEX revealed aptamers which not only bind to a ligand but also are able to turn on fluorescence of different non-fluorescent dyes. An interesting example for an aptamer with such a special function is the Malachite Green Aptamer.
Though we so far mainly discussed functional RNA there are also both DNA aptamers and catalytic DNA which were selected using SELEX as well. As for today the concept of functional nucleic acids in nature has only been found for RNA. Nevertheless DNA aptamers and also catalytic DNA were selected in vitro.